Single Cell Precision Inc. develops advanced diagnostic panels for cancer recurrence, including a unique tool for predicting relapse in HER2-positive breast cancer using standard tumour samples. By providing clinicians with actionable biomarkers and empowering patients with early insight, the company is driving more precise and proactive cancer care.
